MetLife Investment Management’s Core Scientific CORZ Stock Holding History

MetLife Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.38M	Sell	158,982 -4,199	-3%	-$71.6K	0.01%	965
2025 Q4	$2.38M	Sell	163,181 -3,100	-2%	-$54.1K	0.01%	992
2025 Q3	$2.98M	Buy	166,281 +1,082	+0.7%	+$15.9K	0.01%	889
2025 Q2	$2.82M	Buy	165,199 +57,561	+53%	+$576K	0.02%	825
2025 Q1	$779K	Sell	107,638 -1,731	-2%	-$19.7K	﹤0.01%	1486
2024 Q4	$1.54M	Buy	109,369 +5,786	+6%	+$85.5K	0.01%	1194
2024 Q3	$1.23M	Buy	103,583 +58,365	+129%	+$605K	0.01%	1272
2024 Q2	$421K	Buy	+45,218	New	+$231K	﹤0.01%	1822

Other funds holding CORZ

Situational Awareness San Francisco, California $3.86B AUM 334.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return